A benchmark for Personalized Medication in Europe
The annual meeting of Espacio CPI Salud took place in Seville, Spain, on June 11th and 12th, 2024. The CPI format – Innovative Public Tenders – offers a unique opportunity for innovations in Spain. Espacio CPI Salud enhances the impact of funds allocated for innovation, creates spaces for interaction, trains professionals, and strengthens innovators in the public healthcare sector at the national level.
As part of Espacio CPI Salud, PGXperts, together with its consortium partners Illumina and Life & Brain, presented the success story of the MedeA project. The MedeA project was launched by the Health Service of Extremadura (SES) to provide Personalized Medication to the citizens of the Spanish province. This groundbreaking project began in November 2023 with the clinical validation phase. It is set to be available to the population of Extremadura starting in January 2025.
The potential benefits are enormous: a reduction in the side effects of medication and a significant improvement in the quality of life for the citizens of Extremadura.
The MedeA project is unique in the world because it makes personalised medicine available to an entire region and thus represents a milestone in healthcare in Europe.
We thank the organizers for the wonderful event and the opportunity to share our successes and visions. A special thanks goes to our partners Illumina and Life & Brain for the excellent collaboration within the MedeA project.
Find out more about the Espacio CPI Salud here: https://espaciocpisalud.es/ (Spanish version only)
